A study published in the June Lancet Oncology reports early stage breast cancer patients who produce circulating tumor cells (CTC) may be at greater risk for breast cancer recurrence. Until now, lymph node biopsy has been the best predictor of prognosis. More research is needed to learn how to apply this new discovery, but the study is a step forward in understanding what is happening biologically. Anthony Lucci, M.D., professor, and Isabelle Bedrosian, M.D., associate professor, both in...

Could working the night shift alter a woman's body clock enough to cause breast cancer? "One minute you're a healthy person, the next minute you have breast cancer." Ettamay (last name withheld) is up early these days. She lives a much different life than she did when she was a nurse working the night shifts. She would be just getting to sleep at this early morning hour. "I was always exhausted," she says. "I don't know any of the nurses, especially the night shift gals, that weren't...

Previous studies in our laboratory demonstrated that blueberry (BB) extract exhibited antitumor activity againstMDA-MB-231 triple negative breast cancer (TNBC) cells and decreased metastatic potential in vitro. The current study tested 2 doses of whole BB powder, 5 and 10% (wt:wt) in the diet, against MDA-MB-231 tumor growth in female nude mice. In this study, tumor volume was 75%lower in mice fed the 5%BB diet and 60% lower in mice fed the 10%BB diet than in control mice (P # 0.05)....

Meet Maritza Valero. She began her journey at MD Anderson six years ago. With a degree in dentistry, Maritza's six-month volunteer position unexpectedly redirected her career path. She's now a supervisor in the Appearances shop in Mays Clinic. Appearances offers breast forms, bras and other specialty items for cancer patients

Jennifer Litton M.D. makes sense of hormone replacement therapy and its relationship to your risk of getting breast cancer. Please visit: www.mdanderson.org/prevention for more information regarding prevention and screening. Dr. Jennifer Litton, Assistant Professor of Breast Medical Oncology, at The University of Texas MD Anderson Cancer Center discusses hormone replacement therapy and breast cancer risk. View other videos at www.mdanderson.org/videos

Jean-Claude Bradley presents "Accelerating Discovery by Sharing: a case for Open Notebook Science" on May 1, 2011 at the National Breast Cancer Coalition Annual Advocacy Conference in Arlington, VA. First a few examples are provided which show how a lack of transparency in science can retard progress by creating ambiguity. Demonstrations of the use of Open Notebook Science in malaria research, solubility and other chemistry related applications then follow. Examples of web services...

BACKGROUND: The c-Myb transcription factor regulates differentiation and proliferation in hematopoietic cells, stem cells and epithelial cells. Although oncogenic versions of c-Myb were first associated with leukemias, over expression or rearrangement of the c-myb gene is common in several types of solid tumors, including breast cancers. Expression of the c-myb gene in human breast cancer cells is dependent on estrogen stimulation, but little is known about the activities of the c-Myb...

Dr. Sandhya Pruthi, consultant in the breast diagnostic clinic at Mayo Clinic in Rochester, MN, discusses her December 2010 Mayo Clinic Proceedings article http://tinyurl.com/3x2dr7v on diagnostic and management approaches to patients with BRCA mutations that put them at higher risk of breast and/or ovarian cancer.

JRoss 8th Grade Project

A commercial that describes information on Breast Cancer.